Key statistics dashboard for Inogen, Inc. (INGN). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions.
Stock Data
| Price | $5.13 |
| Market Cap | $139M |
| Enterprise Value | $67.4M |
| Beta | 1.71 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -5.71 |
| Price / Book | 0.79 |
| P/S | 0.39 |
| EV/EBITDA | -10.06 |
| EV/Sales | 0.19 |
| EV/FCF | -6.96 |
| P/FCF | -14.36 |
| Earnings Yield | -17.73% |
| FCF Yield | -6.98% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 48.89% |
| EBIT Margin | -7.14% |
| EBITDA Margin | -1.89% |
| Operating Margin | -8.45% |
| Net Margin | -6.94% |
| Return on Equity | -13.17% |
| Return on Assets | -8.61% |
| Return on Invested Capital | -13.35% |
| Return on Capital Employed | -13.94% |
Financial Health
| Current Ratio | 2.74 |
| Quick Ratio | 2.34 |
| Cash Ratio | 1.23 |
| Debt / Equity | 0.09 |
| Debt / Assets | 5.53% |
| Net Debt / EBITDA | 10.67 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 1.58 |
Per-Share Data
| Revenue per share | 13.10 |
| Book Value per share | 6.47 |
| Cash per share | 3.90 |
| FCF per share | -0.36 |
| Tangible Book Value per share | 5.07 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 6 |
| Hold | 4 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 11 |
| Avg rating (1-5) | 0.46 |
Related companies: CATX · EPRX · HCAT · HSDT · NNOX · OM · QTRX
Explore sector: Healthcare · Medical - Devices
More sections of INGN: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks